ketoprofen has been researched along with angiotensin ii in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Silberbauer, K; Sinzinger, H; Winter, M | 1 |
Arakawa, K; Ideishi, M; Ikeda, M; Kato, Y; Masui, S; Urata, H | 1 |
Mannheimer, E; Oppolzer, R; Silberbauer, K; Sinzinger, H | 1 |
Bergström, G; Creutz, J; Göthberg, G; Karlström, G; Rudenstam, J | 1 |
Andrzejak, R; Skoczyńska, A; Wróbel, J | 1 |
Asirvatham-Jeyaraj, N; Fink, GD; King, AJ; Madan, S; Northcott, CA | 1 |
6 other study(ies) available for ketoprofen and angiotensin ii
Article | Year |
---|---|
Prostacyclin (PGI2) activity in rat kidney-stimulated by angiotensin II.
Topics: Angiotensin II; Animals; Epoprostenol; Ketoprofen; Kidney Cortex; Kidney Medulla; Male; Platelet Aggregation; Prostaglandins; Rats | 1979 |
A case of hyperreninemic hypertension with unilateral hydronephrosis.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hydronephrosis; Hypertension, Renal; Ketoprofen; Prostaglandin Antagonists; Renin; Ureteral Obstruction | 1985 |
Prostacyclin synthesis in human lymphatics.
Topics: Adolescent; Adult; Age Factors; Angiotensin II; Blood Platelets; Epoprostenol; Female; Humans; Ketoprofen; Lymphatic System; Male; Middle Aged; Prostaglandins; Sex Factors | 1980 |
Regional renal haemodynamics of angiotensin II infusion under prostaglandin, kinin or converting enzyme inhibition in the Wistar rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aprotinin; Bradykinin; Enalapril; Hemodynamics; Ketoprofen; Kidney Medulla; Losartan; Male; Nitric Oxide; Prostaglandin Antagonists; Rats; Rats, Wistar; Renal Circulation | 2000 |
Lead-cadmium interaction effect on the responsiveness of rat mesenteric vessels to norepinephrine and angiotensin II.
Topics: Analysis of Variance; Angiotensin II; Animals; Cadmium Poisoning; Calcium; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; In Vitro Techniques; Ketoprofen; Lead Poisoning; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Norepinephrine; Papaverine; Potassium Chloride; Rats; Rats, Inbred BUF; Receptors, Angiotensin; Vasoconstriction; Vasoconstrictor Agents; Verapamil | 2001 |
Cyclooxygenase-1 inhibition attenuates angiotensin II-salt hypertension and neurogenic pressor activity in the rat.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Ganglionic Blockers; Hypertension; Ketoprofen; Male; Membrane Proteins; Norepinephrine; Pyrazoles; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Sulfonamides; Sympathetic Nervous System; Time Factors | 2013 |